Navigation Links
The science of sound
Date:4/11/2011

Sonic booms, the science of making music, the impact of noise on people and animals, and bursts of sound-induced light are just some of the intriguing topics that will be presented at the 161st Meeting of the Acoustical Society of America (ASA).

The meeting will take place May 23-27, 2011, in scenic Seattle, Washington, at the Sheraton Seattle Hotel. The ASA offers complimentary press registration to bona fide working journalists; see details below. Journalists may also remotely access meeting information with ASA's World Wide Press Room, which will go live one week before the conference begins.

More than 1,300 papers will be delivered at this premier international meeting of scientific, environmental, and medical acoustics. Highlights include sessions on the impact of noise on land and sea animals; the use of sound to study the body and treat disease; new developments on hearing implants in children and adults; and how noise impacts our medical care, schools, and home life.

Preliminary Meeting Highlights

MONDAY, MAY 23

Listening and Learning in a Simulated Classroom:
Researchers studied how noise affects students' ability to comprehend in the classroom.
http://asa.aip.org/web2/asa/abstracts/search.may11/asa128.html

Underwater Noise Impact on Marine Mammals:
Reducing underwater noise may do more than help marine mammals communicate and navigate. It also may help them cope with many stressful situations, including climate change.
http://asa.aip.org/web2/asa/abstracts/search.may11/asa136.html

Preparing to Hear Thunder on Titan:
Saturn's moon Titan has rain, albeit in the form of methane. It may also have lightning and researchers have proposed a way to detect it by 'listening' for the telltale rumble of alien thund
'/>"/>

Contact: Charles E. Blue
cblue@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Penn presents inaugural symposium on applied mathematics and computational science
2. UW science photo takes second in national contest
3. Global science community to gather in Mozambique
4. 8 National Medals of Science awardees to be honored at gala, then the White House
5. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
6. BioScience tip sheet, October 2008
7. National Science Foundation grants Clemson professors award to develop nanoprobes
8. National Science Foundation grant expands UMCES oyster research
9. Mandate for biofuels production requires science-based policy and global perspective
10. US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board
11. The Science Coalitions 10 questions for the presidential debate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris ... for the US, Canada , ... Asia-Pacific , Middle East , and ... are provided for the period 2013 through 2020. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
Breaking Biology News(10 mins):Personal Data Protection Company Launches New Product 2World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3
... 2013 Disulfiram was the first medication approved for ... works, at least in part, by preventing the metabolism ... in the body quickly cause unpleasant symptoms, including nausea, ... a very strong incentive to avoid drinking. ...
... the fate of the original Otom inhabitants of Xaltocan, ... unknown. Researchers have long wondered whether they assimilated with ... to new anthropological research from The University of Texas ... the answers may lie in DNA. Following this line ...
... Thailand and Morocco have found that DHEA-S may prevent ... patients. In a report appearing in the February 2013 ... they describe how a network of steroid molecules found ... infection leading to brain damage. This suggests that treatment ...
Cached Biology News:Disulfiram: New support for an old addiction drug 2Aztec conquest altered genetics among early Mexico inhabitants, new DNA study shows 2A 'neurosteroid' found to prevent brain injury caused by HIV/AIDS 2
(Date:3/3/2015)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... odour control projects in North America , the ... . "Bidding activity in 2015 continues to be robust" ... high volume year for bidding in 2014, we are pleased to ... orders reflect the organization,s renewed focus on select market segments where ...
(Date:3/3/2015)... , March 3, 2015 Adaptive Biotechnologies ... CFO, is joining its Board of Director as Chair ... officer at Zillow Group, Chad oversees all finance, treasury ... built the company,s core finance, treasury and accounting functions, ... and nine acquisitions. In 2013, he was named Puget ...
(Date:3/3/2015)... March 3, 2015 Fried, Frank, Harris, Shriver ... Lewis has joined the Firm as a partner ... New York office. Mr. Lewis ... as well as other intellectual property and general litigation. ... Lewis represents both plaintiffs and defendants in a range ...
(Date:3/3/2015)... , March 3, 2015  Thingee Corporation, a software ... delivering a presentation entitled, "Technology Adoption: Making Reps, Lives ... through Innovations and Technology ,  in Deerfield ... to 13, 2015. Audiences looking to learn how technology ... want to be in the audience for the Thingee ...
Breaking Biology Technology:Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Thingee to present at 11th Annual Synergistix Users Conference 2
... Sept. 8 Don Margolis, Chairman of,The Repair ... based in,Bangkok, Thailand told The Wall Street Transcript ... future profits inside the stem cell,research sector will ... five years, even for,companies specializing in Repair Stem ...
... 7th International ... Symposium on Uveitis in Germany, ZURICH, Switzerland, Sept. ... today announced that the,company has successfully completed its Phase I ... indications. In,April 2008, ESBATech initiated the Phase I study designed ...
... RNA levels, following 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus ... Copegus(R) -, ... ... 8 Pharmasset, Inc.,(Nasdaq: VRUS ) announces the preliminary results of the fourth cohort ...
Cached Biology Technology:Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript 2ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6